Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

Related Keywords

Australia ,Waterloo ,Ontario ,Canada ,United States ,India ,Rylee Arnold ,Susan Noonan ,Jim Frakes ,Charlesj Fisher Jr ,Company Updates ,University Of Alberta ,Company Contact ,Syntex Inc ,Nasdaq ,University Of Waterloo ,Company Annual Report On Form ,Pfizer Inc ,Abbott Bioresearch Center ,Aethlon Medical Inc ,Hc Wainwright Co ,Drug Administration ,Sa Noonan Communications ,Pardes Biosciences Inc ,Exchange Commission ,Prnewswire Aethlon Medical Inc ,Securities Exchange ,Chief Scientific ,Norganic Chemistry ,Chief Scientific Officer ,Aethlon Medical ,Pardes Biosciences ,Chief Executive Officer ,Medanta Medicity Hospital ,Battelle Labs ,Post Acute Sequelae ,Third Quarter Ended December ,Breakthrough Device ,Securities Act ,Securities Exchange Act ,Emergency Use ,Annual Report ,Nc ,